If the individual is not yet on treatment with a GLP-1 RAs, initiating it before prandial insulin should be considered to minimize the risks of hypoglycemia and weight gain associated with intensive insulin therapy (3). This evidence concerns the gene GLP1R and Hypoglycemia.